Table 5. RNFL in MS patients.

Group	G	G	T	TS	TI	S	I	N	NS	NI	T	TS	TI	S	I	N	NS	NI
	OD	OS	OD	OD	OD	OD	OD	OS	OS	OS	OS	OS	OS	OS	OS	OD	OD	OD
RRMS	100.2	97.3	66.1	128.3	143.1	122.2	131.7	67.5	113.9	111.0	71.7	132.4	140.2	123.7	125.6	79.8	115.9	122.5
without ON
STE	± 2.7	± 2.6	± 3.0	± 4.2	± 6.3	± 5.6	± 4.9	± 2.9	± 6.3	± 6.7	± 2.9	± 4.9	± 5.3	± 4.2	± 4.9	± 4.8	± 8.9	± 7.2
range	73–124	73–120	40–90	90–162	91–191	74–192	94–168	47–96	76–193	75–163	45–88	85–159	105–172	99–170	93–162	51–131	58–221	79–168
RRMS	84.7	87.8	51.3	121.8	118.2	110.8	107.2	66.3	112.5	98.3	58.0	120.8	126.0	116.1	111.4	69.0	103.5	99.5
with ON
STE	± 3.3	± 3.5	± 3.6	± 7.8	± 4.6	± 8.1	± 4.4	± 6.3	± 10.5	± 8.1	± 6.3	± 10.4	± 11.9	± 8.3	± 6.3	± 6.6	± 12.8	± 6.8
range	74–97	77–100	40–67	105–148	110–139	80–133	96–125	50–87	77–150	64–118	41–86	92–165	75–159	85–143	90–125	50–88	55–151	74–118
SPMS	83.0	82.0	51.5	118.5	114.5	112.5	93.5	62.0	85.0	82.5	61.0	112.0	126.5	98.5	104.5	75.0	105.5	72.5
without ON
STE	± 2.0	± 4.0	± 1.5	± 8.5	± 1.5	± 1.5	± 5.5	± 3.0	± 16.0	± 4.5	± 6.0	± 19.0	± 0.5	± 17.5	± 1.5	± 0.0	± 5.5	± 12.5
range	81–85	78–86	50–53	110–127	113–116	111–114	88–99	59–65	69–101	78–87	55–67	93–131	126–127	81–116	103–106	75–75	100–111	60–85
SPMS	99.3	83.7	69.3	143.7	145.0	131.7	121.2	55.0	99.3	100.0	56.7	126.7	117.0	113.2	108.5	71.3	119.3	97.0
with ON
STE	± 9.3	± 10.7	± 7.8	± 15.9	± 18.7	± 9.4	± 8.8	± 6.4	± 4.8	± 18.2	± 14.3	± 5.9	± 17.9	± 4.8	± 17.2	± 10.4	± 8.3	± 10.2
range	81–111	66–103	54–79	112–162	118–181	114–146	104–133	43–65	94–109	66–128	36–84	115–134	93–152	105–122	80–140	51–85	107–135	84–117

Retinal sectors: OD, right eye; OS, left eye; G, global; S, superior; I, inferior; T, temporal; TS, temporal superior; TI, temporal inferior; N, nasal; NS, nasal superior; NI, nasal inferior. All values are given in μm.